• Home
  • About us
  • Our products
  • Your health
  • Responsibility
  • Our work with communities
  • Research & development
  • Investors
  • Media centre
  • Careers
 

GSK in focus

New treatments for cancer

Cancer is the leading cause of death
worldwide. That’s why GSK
is searching for new cancer
treatments that attack the
disease on several fronts.

On 13 March, we announced
the FDA approval of Tykerb,
a new treatment for advanced
or metastatic breast cancer.

Find contact details for GSK offices around the world

Our products
Consumer brands
Prescription medicines
Vaccines
Over £300 million - Our global giving to charitable initiatives was £302 million in 2006, the fourth year that the total has exceeded £300 million.

Learn more about illness:


 

Investors

LSE
1420.00p
+12.00

7 Apr 2007 closed
NYSE
56.24
0.00

7 Apr 2007 closed
London Stock Exchange price updated every minute. Provided by
Hemscott Group Limited

Investor tools
Image of a mother and child
Corporate Responsibility
Review 2006